18Jan 2018

BACTERIAL SPECTRUM OF EXTERNAL OCULAR INFECTIONS: PREVALENCE AND ASSOCIATED IN VITRO ANTIMICROBIAL SUSCEPTIBILITY AND RESISTANCE IN A TERTIARY CARE HOSPITAL.

  • King Abdullah International Medical Research Center / King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: External ocular infections (EOI) can affect the lids, conjunctiva or cornea and may carry serious consequences including visual impairment if not correctly identified and treated. Empirical treatment is usually initiated using broad-spectrum antibiotics before concluding culture and susceptibility testing, this along with casual prescriptions, ineffective dosing and poor patient compliance have contributed to increasing bacterial resistance to commonly used topical antibiotics. Aims: Through this study we aim to establish the prevalence of bacterial EOI and their associated in vitro antimicrobial susceptibility and resistance profiles. Materials and Methods: This cross-sectional study reviewed consecutive microbiological reports of EOI from January 2015 to December 2016. Demographic data and bacterial organisms isolated as well as their susceptibility and resistance results to routine antibiotics used in culture testing were obtained and analyzed. Results: A total of 218 reports of bacterial EOI were attained from 165 patients. Gram-negative organisms represented 71% of all culture reports. H. influenza was the most common etiologic agent representing 26% of all organisms, followed by S. aureus (12%) and P. aeruginosa (10%). Gram-negative isolates had the highest In vitro susceptibility to Amikacin, Colistin and Meropenem. Gram-positive isolates had the highest In vitro susceptibility to Vancomycin. Resistance to multiple antibiotic classes was seen in 39% of cultures. Conclusion: The antimicrobials used in routine culture testing including topical antibiotics commonly used by ophthalmologists had high susceptibility rates overall, but In vitro resistance was encountered for various bacterial organisms. Susceptibility testing allows physician to choose the best antibiotic to avoid inadequate treatment and potential complications including visual impairment and blindness.

  1. Ramesh S, Ramakrishnan R, Bharathi MJ, Amuthan M, Viswanathan S. Prevalence of bacterial pathogens causing ocular infections in South India. Indian J Pathol Microbiol. 2010;53(2):281-6.
  2. Ubani UA. Bacteriology of external ocular infections in Aba, South Eastern Nigeria. Clin Exp Optom. 2009;92(6):482-9.
  3. Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol. 2009;9:13.
  4. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol. 1993;111(12):1665-71.
  5. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472-8.
  6. Smith RE, Flowers CW, Jr. Chronic blepharitis: a review. CLAO J. 1995;21(3):200-7.
  7. Brown L. Resistance to ocular antibiotics: an overview. Clin Exp Optom. 2007;90(4):258-62.
  8. Sharma S. Antibiotic resistance in ocular bacterial pathogens. Indian J Med Microbiol. 2011;29(3):218-22.
  9. Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology. 1999;106(7):1319-23.
  10. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999;106(7):1313-8.
  11. Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology. 1999;106(1):80-5.
  12. Anagaw B, Biadglegne F, Belyhun Y, Anagaw B, Mulu A. Bacteriology of ocular infections and antibiotic susceptibility pattern in Gondar University Hospital, north west Ethiopia. Ethiop Med J. 2011;49(2):117-23.
  13. Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol. 2010;58(6):497-507.
  14. Moeller CT, Branco BC, Yu MC, Farah ME, Santos MA, Hofling-Lima AL. Evaluation of normal ocular bacterial flora with two different culture media. Can J Ophthalmol. 2005;40(4):448-53.
  15. Bharathi MJ, Ramakrishnan R, Meenakshi R, Mittal S, Shivakumar C, Srinivasan M. Microbiological diagnosis of infective keratitis: comparative evaluation of direct microscopy and culture results. Br J Ophthalmol. 2006;90(10):1271-6.
  16. Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol. 2005;89(9):1097-9.
  17. Amato M, Pershing S, Walvick M, Tanaka S. Trends in ophthalmic manifestations of methicillin-resistant Staphylococcus aureus (MRSA) in a northern California pediatric population. J AAPOS. 2013;17(3):243-7.
  18. Chuang CC, Hsiao CH, Tan HY, Ma DH, Lin KK, Chang CJ, et al. Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities. PLoS One. 2012;8(8):e42437.
  19. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med. 1998;158(2):182-9.
  20. Hsiao CH, Chuang CC, Tan HY, Ma DH, Lin KK, Chang CJ, et al. Methicillin-resistant Staphylococcus aureus ocular infection: a 10-year hospital-based study. Ophthalmology. 2012;119(3):522-7.
  21. Kowalski RP, Kowalski TA, Shanks RM, Romanowski EG, Karenchak LM, Mah FS. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection. Cornea. 2013;32(6):830-4.
  22. Oliveira AD, D'Azevedo PA, Francisco W. In vitro activity of fluoroquinolones against ocular bacterial isolates in Sao Paulo, Brazil. Cornea. 2007;26(2):194-8.
  23. Sotozono C, Inagaki K, Fujita A, Koizumi N, Sano Y, Inatomi T, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea. 2002;21(7 Suppl):S94-101.
  24. Zaidi T, Zaidi T, Yoong P, Pier GB. Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. Invest Ophthalmol Vis Sci. 2013;54(7):4430-8.
  25. Mallika P, Asok T, Faisal H, Aziz S, Tan A, Intan G. Neonatal conjunctivitis - a review. Malays Fam Physician. 2008;3(2):77-81.
  26. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214-21.
  27. Isenberg SJ, Apt L, Wood M. The influence of perinatal infective factors on ophthalmia neonatorum. J Pediatr Ophthalmol Strabismus. 1996;33(3):185-8.
  28. Bertino JS, Jr. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol. 2009;3:507-21.
  29. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
  30. Chang VS, Dhaliwal DK, Raju L, Kowalski RP. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review. Cornea. 2015;34(6):698-703.
  31. Blomquist PH. Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:322-45.
  32. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007;144(2):313-5.
  33. Lichtinger A, Yeung SN, Kim P, Amiran MD, Iovieno A, Elbaz U, et al. Shifting trends in bacterial keratitis in Toronto: an 11-year review. Ophthalmology. 2012;119(9):1785-90.
  34. Ong SJ, Huang YC, Tan HY, Ma DH, Lin HC, Yeh LK, et al. Staphylococcus aureus keratitis: a review of hospital cases. PLoS One. 2013;8(11):e80119.
  35. Vola ME, Moriyama AS, Lisboa R, Vola MM, Hirai FE, Bispo PJ, et al. Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections. Arq Bras Oftalmol. 2013;76(6):350-3.
  36. Zhou AW, Lee MC, Rudnisky CJ. Ocular microbiology trends in Edmonton, Alberta: a 10-year review. Can J Ophthalmol. 2012;47(3):301-4.
  37. Elsahn AF, Yildiz EH, Jungkind DL, Abdalla YF, Erdurmus M, Cremona FA, et al. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics. Cornea. 2010;29(10):1131-5.
  38. Magli A, Forte R, Rombetto L, Carelli R. Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery. Int Ophthalmol. 2012;32(1):47-9.
  39. Hayashi S, Suzuki T, Yamaguchi S, Inoue T, Ohashi Y. Genotypic characterization of Staphylococcus aureus isolates from cases of keratitis and healthy conjunctival sacs. Cornea. 2014;33(1):72-6.
  40. Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol. 2013;303(6-7):324-30.
  41. Khosravi AD, Mehdinejad M, Heidari M. Bacteriological findings in patients with ocular infection and antibiotic susceptibility patterns of isolated pathogens. Singapore Med J. 2007;48(8):741-3.

[Saeed Musfer Alzahrani, Saeed Abdullah Al-Ghamdi, Ahmed Mohamed Abdelaal, Essa Ali Abbas, Muhammad Anwar Khan and Abdulfattah Wasel Al-Amri. (2018); BACTERIAL SPECTRUM OF EXTERNAL OCULAR INFECTIONS: PREVALENCE AND ASSOCIATED IN VITRO ANTIMICROBIAL SUSCEPTIBILITY AND RESISTANCE IN A TERTIARY CARE HOSPITAL. Int. J. of Adv. Res. 6 (Jan). 869-878] (ISSN 2320-5407). www.journalijar.com

Saeed Musfer Alzahrani
King Abdullah International Medical Research Center / King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

DOI:

Article DOI: 10.21474/IJAR01/6296      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6296

Download Full Paper

Download PDF No. of Downloads: 37 | No. of Views: 155